• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人前列腺组织和前列腺癌中致癌和抑癌 microRNAs 的细胞类型特异性表达。

Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.

机构信息

The James Buchanan Brady Urologic Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

The Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.

出版信息

Sci Rep. 2018 May 8;8(1):7189. doi: 10.1038/s41598-018-25320-z.

DOI:10.1038/s41598-018-25320-z
PMID:29739972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5940660/
Abstract

MiR-1 and miR-143 are frequently reduced in human prostate cancer (PCa), while miR-141 and miR-21 are frequently elevated. Consequently, these miRNAs have been studied as cell-autonomous tumor suppressors and oncogenes. However, the cell-type specificity of these miRNAs is not well defined in prostate tissue. Through two different microdissection techniques, and droplet digital RT-PCR, we quantified these miRNAs in the stroma and epithelium of radical prostatectomy specimens. In contrast to their purported roles as cell-autonomous tumor suppressors, we found miR-1 and miR-143 expression to be predominantly stromal. Conversely, miR-141 was predominantly epithelial. miR-21 was detected in both stroma and epithelium. Strikingly, the levels of miR-1 and miR-143 were significantly reduced in tumor-associated stroma, but not tumor epithelium. Gene expression analyses in human cell lines, tissues, and prostate-derived stromal cultures support the cell-type selective expression of miR-1, miR-141, and miR-143. Analyses of the PCa Genome Atlas (TCGA-PRAD) showed a strong positive correlation between stromal markers and miR-1 and miR-143, and a strong negative correlation between stromal markers and miR-141. In these tumors, loss of miR-1 and gain of miR-21 was highly associated with biochemical recurrence. These data shed new light on stromal and epithelial miRNA expression in the PCa tumor microenvironment.

摘要

miR-1 和 miR-143 在人类前列腺癌 (PCa) 中经常减少,而 miR-141 和 miR-21 经常增加。因此,这些 miRNA 已被研究为细胞自主的肿瘤抑制因子和癌基因。然而,这些 miRNA 在前列腺组织中的细胞类型特异性尚未得到很好的定义。通过两种不同的显微切割技术和液滴数字 RT-PCR,我们在根治性前列腺切除术标本的基质和上皮中定量了这些 miRNA。与它们作为细胞自主肿瘤抑制因子的假定作用相反,我们发现 miR-1 和 miR-143 的表达主要是基质的。相反,miR-141 主要是上皮的。miR-21 在上皮和基质中均有检测到。引人注目的是,肿瘤相关基质中的 miR-1 和 miR-143 水平显著降低,但肿瘤上皮中没有。人类细胞系、组织和前列腺衍生的基质培养物中的基因表达分析支持 miR-1、miR-141 和 miR-143 的细胞类型选择性表达。对 PCa 基因组图谱 (TCGA-PRAD) 的分析表明,基质标记物与 miR-1 和 miR-143 之间存在强烈的正相关,而基质标记物与 miR-141 之间存在强烈的负相关。在这些肿瘤中,miR-1 的丢失和 miR-21 的获得与生化复发高度相关。这些数据为 PCa 肿瘤微环境中的基质和上皮 miRNA 表达提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/a91de1893845/41598_2018_25320_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/ffb361e9dc71/41598_2018_25320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/680be25c77b5/41598_2018_25320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/4ea7c0b1518b/41598_2018_25320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/79de7ce106db/41598_2018_25320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/6b1cd69dae91/41598_2018_25320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/a91de1893845/41598_2018_25320_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/ffb361e9dc71/41598_2018_25320_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/680be25c77b5/41598_2018_25320_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/4ea7c0b1518b/41598_2018_25320_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/79de7ce106db/41598_2018_25320_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/6b1cd69dae91/41598_2018_25320_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd2b/5940660/a91de1893845/41598_2018_25320_Fig6_HTML.jpg

相似文献

1
Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.人前列腺组织和前列腺癌中致癌和抑癌 microRNAs 的细胞类型特异性表达。
Sci Rep. 2018 May 8;8(1):7189. doi: 10.1038/s41598-018-25320-z.
2
Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.前列腺癌根治术后复发的miRNA表达谱的Meta分析。
PLoS One. 2017 Jun 26;12(6):e0179543. doi: 10.1371/journal.pone.0179543. eCollection 2017.
3
Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.MiR-21的基质表达可预测Gleason评分为6分的前列腺癌患者的生化复发。
PLoS One. 2014 Nov 17;9(11):e113039. doi: 10.1371/journal.pone.0113039. eCollection 2014.
4
High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.前列腺癌基质中 PDGFR-β 的高表达与临床和生化前列腺癌复发独立相关。
Sci Rep. 2017 Feb 24;7:43378. doi: 10.1038/srep43378.
5
The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.Let-7c、miR-21、miR-145、miR-182 和 miR-221 与低危前列腺癌患者临床病理参数的相关性。
Prostate. 2019 Jul;79(10):1125-1132. doi: 10.1002/pros.23825. Epub 2019 May 2.
6
MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.微小RNA-301a调控E-钙黏蛋白的表达,并可预测前列腺癌复发。
Prostate. 2016 Jul;76(10):869-84. doi: 10.1002/pros.23177. Epub 2016 Mar 15.
7
Asporin is a stromally expressed marker associated with prostate cancer progression.阿朴脂蛋白是一种与前列腺癌进展相关的基质表达标志物。
Br J Cancer. 2017 Mar 14;116(6):775-784. doi: 10.1038/bjc.2017.15. Epub 2017 Feb 2.
8
Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.使用激光捕获显微切割技术分析前列腺癌上皮细胞和间质基质细胞中的基因表达。
BMC Cancer. 2010 Apr 28;10:165. doi: 10.1186/1471-2407-10-165.
9
Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?基于组织的 microRNAs 作为根治性前列腺切除术后生化复发的预测因子:我们能从过去的研究中学到什么?
Int J Mol Sci. 2017 Sep 21;18(10):2023. doi: 10.3390/ijms18102023.
10
High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?正常上皮组织中高表达的 miR-205 与生化失败相关——这是否表明前列腺癌中存在上皮细胞间的串扰?
Sci Rep. 2017 Nov 24;7(1):16308. doi: 10.1038/s41598-017-16556-2.

引用本文的文献

1
Impact of protein kinase CK2 downregulation and inhibition on oncomir clusters 17 ~ 92 and 106b ~ 25 in prostate, breast, and head and neck cancers.蛋白激酶 CK2 下调和抑制对前列腺癌、乳腺癌和头颈部癌中 oncomir 簇 17~92 和 106b~25 的影响。
Mol Med. 2024 Oct 11;30(1):175. doi: 10.1186/s10020-024-00937-1.
2
Prostate-derived circulating microRNAs add prognostic value to prostate cancer risk calculators.前列腺来源的循环微小RNA可为前列腺癌风险计算器增加预后价值。
J Extracell Biol. 2023 Nov;2(11). doi: 10.1002/jex2.122. Epub 2023 Nov 6.
3
Molecular Insight into Prostate Cancer: Preventive Role of Selective Bioactive Molecules.

本文引用的文献

1
Toward the human cellular microRNAome.人类细胞 microRNAome 研究进展
Genome Res. 2017 Oct;27(10):1769-1781. doi: 10.1101/gr.222067.117. Epub 2017 Sep 6.
2
Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate.人前列腺肿瘤转化过程中的间充质干细胞浸润
Oncotarget. 2017 Jul 18;8(29):46710-46727. doi: 10.18632/oncotarget.17362.
3
MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes.MicroRNA-141 通过靶向一组促进转移的基因来抑制前列腺癌干细胞和转移。
前列腺癌的分子洞察:选择性生物活性分子的预防作用
Life (Basel). 2023 Sep 27;13(10):1976. doi: 10.3390/life13101976.
4
Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer.miR-143-3p靶向AKT1可抑制前列腺癌中的上皮-间质转化
Cells. 2023 Sep 5;12(18):2207. doi: 10.3390/cells12182207.
5
miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia.miRNA-21 作为印度尼西亚前列腺癌患者的高潜力前列腺癌生物标志物。
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):1095-1099. doi: 10.31557/APJCP.2023.24.3.1095.
6
Expression of Selected miRNAs in Normal and Cancer-Associated Fibroblasts and in BxPc3 and MIA PaCa-2 Cell Lines of Pancreatic Ductal Adenocarcinoma.正常及癌相关成纤维细胞以及胰腺导管腺癌的BxPc3和MIA PaCa-2细胞系中所选微小RNA的表达
Int J Mol Sci. 2023 Feb 10;24(4):3617. doi: 10.3390/ijms24043617.
7
MiR-21 Is Induced by Hypoxia and Down-Regulates in Prostate Cancer.微小RNA-21由缺氧诱导并在前列腺癌中下调。
Cancers (Basel). 2023 Feb 17;15(4):1291. doi: 10.3390/cancers15041291.
8
A curated human cellular microRNAome based on 196 primary cell types.基于 196 种原代细胞类型的精心挑选的人类细胞 microRNAome。
Gigascience. 2022 Aug 25;11. doi: 10.1093/gigascience/giac083.
9
Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.犬类和人类前列腺癌的比较病理生物学:现状与未来方向
Cancers (Basel). 2022 May 31;14(11):2727. doi: 10.3390/cancers14112727.
10
Retracted Article: Long noncoding RNA PCA3 regulates glycolysis, viability and apoptosis by mediating the miR-1/CDK4 axis in prostate cancer.撤稿文章:长链非编码RNA PCA3通过介导miR-1/CDK4轴调控前列腺癌的糖酵解、生存能力和凋亡。
RSC Adv. 2018 Nov 8;8(66):37564-37572. doi: 10.1039/c8ra08083f. eCollection 2018 Nov 7.
Nat Commun. 2017 Jan 23;8:14270. doi: 10.1038/ncomms14270.
4
microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.微小RNA和DICER1在前列腺基质中受1,25-二羟维生素D调控。
J Steroid Biochem Mol Biol. 2017 Mar;167:192-202. doi: 10.1016/j.jsbmb.2017.01.004. Epub 2017 Jan 12.
5
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
6
MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression.微小RNA-141-3p通过抑制克鲁ppel样因子9的表达促进前列腺癌细胞增殖。
Biochem Biophys Res Commun. 2017 Jan 22;482(4):1381-1386. doi: 10.1016/j.bbrc.2016.12.045. Epub 2016 Dec 9.
7
miR-15/miR-16 loss, miR-21 upregulation, or deregulation of their target genes predicts poor prognosis in prostate cancer patients.miR-15/miR-16缺失、miR-21上调或其靶基因失调预示前列腺癌患者预后不良。
Mol Cell Oncol. 2015 Dec 10;3(4):e1109744. doi: 10.1080/23723556.2015.1109744. eCollection 2016 Jul.
8
MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.微小RNA在前列腺癌中的表达与功能:当前知识及发现机遇综述
Asian J Androl. 2016 Jul-Aug;18(4):559-67. doi: 10.4103/1008-682X.177839.
9
High-Throughput Microdissection for Next-Generation Sequencing.用于下一代测序的高通量显微切割
PLoS One. 2016 Mar 21;11(3):e0151775. doi: 10.1371/journal.pone.0151775. eCollection 2016.
10
The Potential of MicroRNAs as Prostate Cancer Biomarkers.微小RNA作为前列腺癌生物标志物的潜力
Eur Urol. 2016 Aug;70(2):312-22. doi: 10.1016/j.eururo.2015.12.054. Epub 2016 Jan 22.